FORCE’s eXamining the Relevance of Articles for Young Survivors (XRAYS) program is a reliable resource for breast cancer research-related news and information. XRAYS reviews new breast cancer research, provides plain-language summaries, and rates how the media covered the topic. XRAYS is funded by the CDC.
Men with breast cancer
Triple negative breast cancer
Her2+ breast cancer
People with a genetic mutation linked to cancer risk
Breast cancer survivors
Women under 45
Women over 45
Healthy people with average cancer risk
Special populations: women newly diagnosed with breast cancer
Vitamin D is most known for its role in maintaining bone health. Recent research looked at its role in many other biological processes and diseases, including breast cancer. In this study, researchers found that breast cancer patients who had the highest amounts of vitamin D in their blood (slightly over the recommended levels) had better health outcomes, including overall survival, than women with lower amounts of vitamin D. This finding adds to the growing evidence for the role of vitamin D in cancer, but it does not change how breast cancer is prevented or treated. (1/10/17)
Whether women’s vitamin D blood levels at the time of diagnosis are related to their health outcomes.
Vitamin D is important for bone health and is also implicated in other bodily processes. Some research suggests that vitamin D is involved in breast cancer, but its role is not well understood. Researchers in this study wanted to know if there is a link between the level of vitamin D in a woman’s blood at the time of her breast cancer diagnosis and her prognosis (how well she does after the diagnosis), including measurements of breast cancer stage and survival.
This study suggests that women who have high vitamin D levels (slightly higher than the level recommended by the National Institute of Health) have better overall survival compared to women with lower levels. These findings agree with several other studies of vitamin D levels and breast cancer survival outcomes. But much more work needs to be done before these findings can be applied to preventing breast cancer or recurrence. This study’s results do not mean that increasing vitamin D consumption after a breast cancer diagnosis will improve patient survival; it just means that patients who had better survival were seen to have higher vitamin D levels. The researchers do not know if better survival is directly related to vitamin D.
Ultimately, vitamin D is very important for all women. It helps calcium absorption in the gut, keeps bones strong, and also aids in some functions of immune function, cell growth, and reduction of inflammation. Vitamin D deficiencies result in diseases that cause weak bones and contribute to osteoporosis, so it is important to maintain adequate levels of vitamin D in our bodies whether or not it affects cancer risk or prognosis. Women concerned about their vitamin D levels should consult with their health care provider who can order blood tests to check their vitamin D levels and advise them if dietary changes or supplements are necessary.
Medical News Today
New York Times
Previous studies have tried to determine whether there are potential associations between vitamin D levels in the blood and breast cancer risk, but have concluded with mixed results: some say there is an association while others say there is not. But fewer studies have looked at whether there is an association between vitamin D blood levels at the time of diagnosis and breast cancer prognosis; studies that did involve this relationship assessed overall survival, but not deaths from breast cancer. As vitamin D deficiencies have known effects beyond any role in breast cancer, lower overall survival in women with low blood levels of vitamin D may be due to causes unrelated to their breast cancer.
Song Yao and colleagues from the Department of Cancer Prevention and Control at the Rosewell Park Cancer Institute performed a prospective study (meaning they designed the study and collected the data themselves rather than looking back on information collected by others or relying on patients’ recollections). They looked at the association between blood vitamin D levels at the time of diagnosis and breast cancer prognosis.
Does a woman’s amount of vitamin D in her blood indicate how well she will do after a breast cancer diagnosis?
This study (called the Pathways Study) included 1,666 women who were diagnosed with invasive breast cancer. This population was established at Kaiser Permanente Northern California and was designed to specifically study factors that are associated with breast cancer recurrence and survival. The women’s vitamin D levels were measured shortly after diagnosis and were then followed for up to 96 months after they were enrolled in the study in which researchers tracked participants’ health outcomes.
Vitamin D has several forms in the blood. In this study, the researchers measured a form called 25-hydroxyvitamin D, which according to the National Institutes of Health (NIH) is the best indicator of a person’s overall vitamin D status.
The NIH states that a vitamin D level of 20 ng/mL or greater is considered adequate for bone and overall health. For this study, the researchers divided the women into three groups based on their vitamin D blood levels:
It is important to understand that the link identified in this study between high vitamin D levels in the blood and better breast cancer survival after diagnosis does not necessarily mean that vitamin D directly caused the better prognosis or that having higher levels of vitamin D in the blood prevents breast cancer diagnosis or recurrence. Other factors that were not measured by the study may have played a role in the women’s improved survival.
This study suggests that women who are diagnosed with breast cancer and have high levels of vitamin D have a better prognosis than women with lower levels of vitamin D. More work needs to be done to further understand how this can help women with breast cancer in the clinic. In the meantime, women should maintain a healthy vitamin D level, which benefits their overall health.
Share your thoughts on this XRAYS article by taking our brief survey
Yao S, Kwan ML, Ergas IJ, et al. “Association of Serum Level of Vitamin D at Diagnosis with Breast Cancer Survival A Case-Cohort Analysis in the Pathways Study.” JAMA Oncology. Published online first on November 10, 2016.
National Institutes of Health, Office of Dietary Supplements. “Vitamin D.”
FORCE Information: Diet and Nutrition
Be Empowered Webinar: How Do I Get Motivated? Changing Your Lifestyle and Diet
Be Empowered Webinar: Nutrition and Supplements